Purine receptors: GPCR structure and agonist design

Molecular Interventions

Volumn 4, Issue 6, 2004, Pages 337-347

  Jacobson, Kenneth A ^a   Kim, Soo Kyung ^a   Costanzi, Stefano ^a   Gao, Zhan Guo ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; MRS 1292; MRS 1898; MRS 2365; MRS 3558; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

BINDING SITE; CHO CELL; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; GENE THERAPY; HUMAN; HYPOTHESIS; MOLECULAR MODEL; NONHUMAN; PROTEIN ENGINEERING; PROTEIN STRUCTURE; RAT; RECEPTOR UPREGULATION; REVIEW; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN ENGINEERING; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 12344310323     PISSN: 15340384     EISSN: None     Source Type: Journal    
DOI: 10.1124/mi.4.6.7     Document Type: Review

References (55)

1. Gershengorn, M.C. and Osman, R. Minireview: Insights into G protein-coupled receptor function using molecular models. Endocrinology 142, 2-10 (2001).
2. Visiers, I., Ballesteros, J.A., and Weinstein, H. Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol. 343, 329-371 (2002).
3. Ballesteros, J.A., Shi, L., and Javitch, J.A. Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60, 1-19 (2001).
4. Palczewski, K. et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745 (2000).
5. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N., and Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adeonsine receptors. Pharmacol. Rev. 53, 527-552 (2001).
6. von Kügelgen, I. and Wetter, A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 362, 310-323 (2000).
7. Haskó, G. and Cronstein, B.N. Adenosine: An endogenous regulator of innate immunity. Trends Immunol. 25, 33-39 (2004).
8. Jacobson, K.A., von Lubitz, D.K.J.E., Daly, J.W., and Fredholm, B.B. Adenosine receptor ligands: Differences with acute and chronic treatment. Trends Pharmacol. Sci. 17, 108-113 (1996).
9. Nakano, A., Cohen, M.V., and Downey, J.M. Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol. Ther. 86, 263-275 (2000).
10. 3 receptor. FASEB J. 12, 1785-1792 (1998).
11. Fishman, P., Madi, L., Bar-Yehuda, S., Barer, F., Del Valle, L., and Khalili, K. Evidence for involvement of Wnt signaling pathway in IB-MECA medicated suppression of melanoma cells. Oncogene. 21 4060-4064 (2002).
12. 2A agonist and antagonist. J. Med. Chem. 46, 4847-4859 (2003).
13. Müller, C.E. Adenosine receptor ligands - recent developments. Curr. Med. Chem. 7, 1269-1288 (2000).
14. 3 receptor. J. Med. Chem. 45, 420-429 (2002).
15. 3 adenosine receptors. Biochem. Pharmacol. 65, 1675-1684 (2003).
16. 3 adenosine receptors: Modification of the ribose moiety. Biochem. Pharmacol. 67, 893-901 (2004).
17. Ohno, M., Gao, Z.G., van Rompaey, P. et al. Modulation of adenosine receptor affinity and intrinsic efficacy in nucleosides substituted at the 2-position. Bioorganic Med. Chem. 12, 2995-3007 (2004).
18. 6 (2-phenylethyl)adenosine derivatives as potent ligands. Bioorganic Med. Chem. 12, 2021-2034 (2004).
19. Gao, Z.G., Mamedova, L., Chen, P., and Jacobson, K.A. 2-Substituted adenosine derivatives: Affinity and efficacy at four subtypes of human adenosine receptors. Biochem. Pharmacol. 68 1985-1993 (2004).
20. Black, J.W., Durant, G.J., Emmett, J.C., and Ganellin, C.R. Sulphur-methylene isosterism in the development of metiamide, a new histamine H2-receptor antagonist. Nature 248, 65-67 (1974).
21. Webb, T.E., Simon, J., Krishek, B.J., Bateson, A.N., Smart, T.G., King, B.F., Burnstock, G., and Barnard, E.A. Cloning and functional expression of a brain G protein-coupled ATP receptor. FEBS Lett. 324, 219-225 (1993).
22. + stem and progenitor cells. BMC Immunol. 5, 16 (2004).
23. Dubyak, G.R. Knock-out mice reveal tissue-specific roles of P2Y receptor subtypes in different epithelia. Mol. Pharmacol. 63 773-776 (2003).
24. Picher, M., Burch, L.H., and Boucher, R.C. Metabolism of P2 receptor agonists in human airways: Implications for mucociliary clearance and cystic fibrosis. J. Biol. Chem. 279, 20234-20241 (2004).
25. Leon, C., Ravanat, C., Freund, M., Cazenave, J.P., and Gachet, C. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler. Thromb. Vasc. Biol. 23, 1941-1947 (2003).
26. Kunapuli, S.P., Ding, Z., Dorsam, R.T., Kim, S., Murugappan, S., and Quinton, T.M. ADP receptors - targets for developing antithrombotic agents. Curr. Pharm. Design 9, 2303-2316 (2003).
27. Filipek, S., Krzysko, K.A., Fotiadis, D., Liang, Y., Saperstein, D.A., Engel, A., and Palczewski, K. A concept for G protein activation by G protein-coupled receptor dimers: The transducin/rhodopsin interface. Photochem. Photobiol. Sci. 3, 628-638 (2004).
28. Furse, K.E. and Lybrand, T.P. Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists. J. Med. Chem. 46, 4450-4462(2003).
29. Shacham, S., Marantz, Y., Bar-Haim, S. et al. PREDICT modeling and in-silico screening for G protein-coupled receptors. Proteins. 57, 51-86 (2004).
30. Kim, H.S., Ohno, M., Xu, B. et al. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a Northern conformation: Enhanced potency as P2Y1 receptor antagonists. J. Med. Chem. 46, 4974-4987 (2003).
31. 3 adenosine receptor agonists. J. Med. Chem. (in press).
32. 3 adenosine receptor. J. Biol. Chem. 277, 19056-19063 (2002).
33. Costanzi, S., Mamedova, L., Gao, Z.G., and Jacobson, K.A. Architecture of P2Y nucleotide receptors: Structural comparison based on sequence analysis, mutagenesis, and homology modeling. J. Med. Chem. 47, 5393-5404 (2004).
34. 3 adenosine receptors by site-directed mutagenesis. Biochem. Biophys. Res. Comm. 284, 596-601 (2001).
35. Jacobson, K.A., Gao, Z.G., Chen, A. et al. Neoceptor concept based on molecular complementarity in GPCRs: A mutant adenosine A3 receptor with selectively enhanced affinity for amine-modified nucleosides J. Med. Chem. 44, 4125-4136 (2001).
36. Gao, Z.G., Kim, S.K., Biadatti, T., Chen, W., Lee, K., Barak, D., Kim, S.G., Johnson, C.R., and Jacobson, K.A. Structural determinants of A3 adenosine receptor activation: Nucleoside ligands at the agonist/antagonist boundary. J. Med. Chem. 45, 4471-4484 (2002).
37. Altona, C., and Sundaralingham, M. Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation. J. Am. Chem. Soc. 94, 8205 (1972).
38. Marquez, V.E., Siddiqui, M.A., Ezzitouni, A., Russ, P., Wang, J., Wagner, R.W., and Matteucci, M.D. Nucleosides with a twist. Can fixed forms of sugar ring pucker influence biological activity in nucleosides and oligonucleotides? J. Med. Chem. 39, 3739-3747 (1996).
39. 6 receptors. J. Med. Chem. 45, 208-218 (2002).
40. Jacobson, K.A., Ji, X.D., Li, A.H., Melman, N., Siddiqui, M.A., Shin, K.J., Marquez, V.E., and Ravi, R.G. Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. J. Med. Chem. 43, 2196-2203 (2000).
41. 3 adenosine receptor as an example. Trends Pharm. Sci. (in press).
42. Tucker, A.L., Robeva, A.S., Taylor, H.E., Holeton, D., Bockner, M., Lynch, K.R., and Linden, J. A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. J. Biol. Chem. 269, 27900-27906 (1994).
43. Rivkees, S.A., Barbhaiya, H., and IJzerman, A. Identification of the adenine binding site of the human A1 adenosine receptor. J. Biol. Chem. 274, 3617-3621 (1999).
44. Ghanouni, P., Steenhuis, J.J., Farrens, D.L., and Kobilka, B.K. Agonist-induced conformational changes in the G protein-coupling domain of the beta 2 adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 5997-6002 (2001).
45. Hoist, B., Holliday, N.D., Bach, A., Elling, C.E., Cox, H.M., and Schwartz, T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 10.1074/jbc.M40767200.
46. 3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure (unpublished results).
47. 1 receptor. Mol. Pharmacol. 50, 1323-1329 (1996).
48. Jacobson, K.A., Costanzi, S., Ohno, M., Joshi, B.V., Besada, P., Xu, B., and Tchilibon, S. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Current Trends Med. Chem. 4, 805-819 (2004).
49. 13 receptors by conformational constraint of an ADP analogue. J. Pharm. Exp. Ther. 311, 1038-1043 (2004).
50. 1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites, J. Med. Chem. 41, 1456-1466 (1998).
51. Ohno, M., Costanzi, S., Kim, H.S., Kempeneers, V., Vastmans, K., Maddileti, S., Gao, Z.G., Harden, T.K., and Jacobson, K.A. Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and L-α -threofuranosyl ring systems: Interactions with P2Y receptors, Bioorganic Med. Chem. 12, 5619-5630 (2004).
52. Leon, C., Alex, M., Klocke, A., Morgenstern, E., Moosbauer, C., Eckly, A., Spannagl, M., Gachet, C., and Engelmann, B. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 103, 594-600 (2004).
53. 1 receptor. Biochem. Pharmacol. 68, 1995-2002 (2004).
54. 1 agonists with diminished hypotensive effects, J. Med. Chem. 42, 3463-3477 (1999).
55. 2A adenosine receptor and its agonists. Chemistry and Biology (in press).